Log In
Print this Print this

IsoFlux NGS Assay

  Manage Alerts
Collapse Summary General Information
Company Fluxion Biosciences Inc.
DescriptionAssay to detect mutation from circulating tumor cells (CTCs)
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationCancer, Diagnostic
Indication DetailsDetect mutations in circulating tumor cells (CTCs)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today